There are 383 resources available
193P - Safety and efficacy of immmunotherapy rechallenge following a previous immune-induced interstial lung disease
Presenter: Célia Joseph
Session: Poster Display session
194P - Modelling strategies to combine multiple serum tumor biomarkers for early prediction of immunotherapy non-response in non-small cell lung cancer.
Presenter: Freek van Delft
Session: Poster Display session
195P - Radiomics and dosiomics signature from whole lung predicts radiation pneumonitis : A model development study with prospective external validation and decision-curve analysis
Presenter: Zhen Zhang
Session: Poster Display session
158P - Real-world management of patients with EGFR exon 20-mutant NSCLC in the precision oncology era: First report from the European EXOTIC registry
Presenter: Giannis Mountzios
Session: Poster Display session
159P - ReWARD study - Real world ALK resistance data: A single center experience
Presenter: Ullas Batra
Session: Poster Display session
160P - LungMetrics India: Molecular epidemiology and testing patterns in 4,773 non squamous NSCLC patients
Presenter: Ullas Batra
Session: Poster Display session
161P - Bayesian network structure for predicting two-year survival inpatients diagnosed with non small cell lung cancer
Presenter: Biche Osong
Session: Poster Display session
162P - A CT radiomics model to predict overall survival following curative-intent radiotherapy for stage I-III non-small cell lung cancer
Presenter: Sumeet Hindocha
Session: Poster Display session
163P - Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: Findings from the CAVE-lung trial
Presenter: Carminia Maria Della Corte
Session: Poster Display session
164P - Immune modulatory functions of lurbinectedin in small cell lung cancer and malignant pleural mesothelioma patients
Presenter: Luca Cantini
Session: Poster Display session